Home Syllabus Small Group / Patient Exam Video Library Contact Faculty Login

Syllabus > Year: 2 Winter 2007 - 2008
  Controversies in Medicine: Pharmaceutical Companies (Large then Small Groups) -
  January 22, 2008    1:00 PM - 3:00 PM
  John Santa M.D., M.P.H.; Panel &
  This is a student-planned and -run session. There will be a panel discussion-- speakers t.b.a.

DISCLOSURE Faculty who assisted in the development of this curriculum (John Santa MD MPH) have financial relationships (consulting contract) with consumer groups (Community Catalyst, Consumers Union) doing advocacy work related to prescription drugs.
Assignment Due Today:


   
Student Readings:
Syllabus    AMSA’s Pharm Free Scorecard 2007 
Syllabus    A National Survey of Physician Industry Relationships, Commonwealth Fund Report summary of NEJM 2007 paper. 
Syllabus    Health Industry Practices That Create Conflict of Interest. A Policy Proposal for Academic Medical Centers - JAMA – 2006 abstract 
Syllabus    Medical Students Exposure to and Attitudes About Drug Company Interactions – JAMA – 2005 - abstract 
Syllabus    Scope and Impact of Financial Conflicts of Interest in Biomedical Research – JAMA - 2003 abstract 
Syllabus    Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift? - JAMA - abstract  
Syllabus    Lecture PowerPoint 
Syllabus    Lecture PowerPoint (Oregon Panel) 
Faculty Only:
   
Internet Sites:
   
Session Goal: To familiarize students with issues surrounding pharmaceutical sales strategies.

To prepare students for choices they need to make when approached by sales and marketing staff from a pharmaceutical company.

To increase awareness of physician/industry relationships.

Integrate economic incentive knowledge with delivery system design to predict health care outcomes for individuals and populations.

Increase understanding of the impact of health policy change.

 
 
Student Objectives:
Identify external financial influences on the practice of medicine.

Describe pharmaceutical sales and marketing approaches in general.

Identify pros and cons of samples for individual patients/ patient populations in general as well as physicians/ health care systems as a whole.

Describe the effect of financial incentives.

Identify conflicts of interest and strategies to resolve such conflicts.

Identify areas in which health policy (how groups of people explicitly relate and work with each other) is important and possibly changing.

Describe barriers to and facilitators of, change in policy.

Demonstrate understanding of the impact of health policy change.

 
Small Group Activities:
  1. Discuss initial reaction to the panel. Have students share personal experiences.


  2. Have students discuss how they will deal with the "free lunch" issue.


  3. With the remaining time discuss the following scenarios:

    a. How would you handle the patient of your partner who has had a bad reaction to a drug sample? There is no note in the chart showing which antibiotic was provided and the patient doesn't know what it is.
    b. A patient needs to take an expensive medication the rest of their life and can't afford it unless they get samples. It's against your office policy to have samples...what would you do?
    c. You and your partner disagree about your office sample policy. How will you resolve this? He is not as busy as you are and enjoys the additional income from giving talks.
    d. How do you handle a patient who needs medication and insists on getting samples of a brand-name medication rather than a prescription for a cheaper generic?